SEC Form 4/A · accession 0001493152-15-001522
OncBioMune Pharmaceuticals, Inc · OBMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Constantin Dietrich
Officer — Chief Executive Officer · Director
Period of report
Apr 14, 2015
Accepted (ET)
Apr 20, 2015 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362703
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 20, 2015 | J | 17,774,136 | — | D | 18,074,136 | D | |
| Common StockF1 | Apr 20, 2015 | J | 17,774,136 | — | D | 300,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the cancellation of the previously reported April 14, 2015 transaction by the reporting person due to his failure to pay the consideration for the purchase price of the common stock.